Login

Christoph Vilanek of Freenet AG speaks at the 25 Years MCI event, while Thierry Bernard, CEO of QIAGEN N.V., participates in the Distinguished Guest Livetalk. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek, CEO of Freenet

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Celebrating Connections: Spreading Joy and Kindness|Jim McCann,Founder,1-800-Flowers
00:10:00
Impact of MiFID II on Market Transparency and Trading Shifts Analyzed
00:10:00
Hinda Gharbi was appointed CEO of Bureau Veritas
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
South Harz Potash: Overview and Investment Potential
00:10:00
Exploring the Future of Nuclear Power: Uranium Opportunities in Namibia and Australia
00:10:00
Bulent Altan Discusses Mynaric's Role in the Evolving Laser Communication Landscape |Bulent Altan , CEO , Mynaric AG.
00:10:00
Navigating Client Relationships in Asset Management
00:10:00
Demystifying Securitized Fixed Income: Opportunities and Strategies for Investors | John Kerschner, CFA - Head of US Securitised Products | Portfolio Manager of Janus Henderson Investors
00:10:00
John Stossel on Government Inefficiency and Individual Success|John Stossel
00:10:00
Exploring Brazil's Golden Potential: Cabral Gold's Promising Ventures at One-to-One Mining Conference
00:10:00
Enhancing Customer Engagement Through Digital Leadership | Frank Vang-Jensen, CEO, Nordea .

© 2017 - Neuhu+